激素敏感性前列腺癌早期化疗的最新进展
发布时间：2018-07-31 09:10
【摘要】：目前转移性激素敏感性前列腺癌一线治疗方案仍然是内分泌治疗,多西他赛和强的松是转移性去势抵抗性前列腺癌的一线治疗方案。近年来多西他赛在激素敏感性前列腺癌中早期介入成为研究热点。本文将结合近期相关的临床研究结果和指南对多西他赛在激素敏感性前列腺癌中的应用进展做一综述。
[Abstract]:Endocrine therapy is still the first line therapy for metastatic hormone sensitive prostate cancer, and docetaxel and prednisone are the first line therapy for metastatic castrated resistant prostate cancer. In recent years, docetaxel early intervention in hormone-sensitive prostate cancer has become a hot topic. This article reviews the application of docetaxel in hormone-sensitive prostate cancer in combination with recent clinical findings and guidelines.
【作者单位】： 重庆医科大学附属第一医院泌尿外科;
【分类号】：R737.25
本文编号：2155109
[Abstract]:Endocrine therapy is still the first line therapy for metastatic hormone sensitive prostate cancer, and docetaxel and prednisone are the first line therapy for metastatic castrated resistant prostate cancer. In recent years, docetaxel early intervention in hormone-sensitive prostate cancer has become a hot topic. This article reviews the application of docetaxel in hormone-sensitive prostate cancer in combination with recent clinical findings and guidelines.
【作者单位】： 重庆医科大学附属第一医院泌尿外科;
【分类号】：R737.25
【相似文献】
相关期刊论文 前1条
1 彭家清;周松林;张克凯;徐立;邢天柱;熊燕;彭君;秦鹏;;原发性肾病综合征患者激素敏感性与糖皮质激素受体亚型的关系研究[J];医学研究杂志;2009年06期
，本文编号：2155109
本文链接：https://www.wllwen.com/yixuelunwen/zlx/2155109.html
